Ammonium glycyrrhizinate API Market Size, Production, Sales, Average Product Price, Market Share, Import vs Export

Ammonium glycyrrhizinate API Market surges with robust expansion.

The Ammonium glycyrrhizinate API Market displays remarkable momentum, propelled by escalating demand in pharmaceutical formulations worldwide. For instance, annual production volumes have climbed by over 12% since 2023, reaching approximately 2,500 metric tons globally as per Datavagyanik assessments. This surge stems from its potent anti-inflammatory and hepatoprotective properties, making it indispensable in liver tonics and dermatological creams. Such as in Asia-Pacific regions, where herbal-derived APIs like ammonium glycyrrhizinate dominate 35% of the natural extract segment, driving the Ammonium glycyrrhizinate API Market toward a projected value of $450 million by 2028.

Ammonium glycyrrhizinate API Market witnesses steady volume growth.

In the Ammonium glycyrrhizinate API Market, production capacities have expanded significantly, with top facilities in China and India boosting output by 15% year-on-year to meet surging needs. For example, key players have invested $50 million in new extraction plants, enabling purity levels above 98% to cater to stringent regulatory standards. This growth aligns with rising applications in oral supplements, where demand has doubled in the last two years due to consumer shifts toward natural corticosteroids alternatives. Consequently, the Ammonium glycyrrhizinate API Market benefits from diversified supply chains, reducing dependency on single regions.

Ammonium glycyrrhizinate API Market benefits from rising pharma integrations.

The Ammonium glycyrrhizinate API Market thrives as pharmaceutical giants integrate it into blockbuster formulations for skin disorders and gastrointestinal aids. Take, for instance, its role in over 200 registered drugs across Europe, contributing to a 20% uptick in finished dosage sales. According to Datavagyanik, this integration has fueled a compound annual growth rate (CAGR) of 10.5% in the Ammonium glycyrrhizinate API Market from 2024 onward. Examples include combo therapies for eczema, where efficacy trials show 30% faster symptom relief compared to synthetic analogs.

Ammonium glycyrrhizinate API Market propelled by anti-inflammatory demand.

Anti-inflammatory applications anchor the Ammonium glycyrrhizinate API Market, with global consumption in topical ointments jumping 18% amid chronic disease prevalence. For example, in North America, prescriptions for glycyrrhizinate-based creams rose by 25% in 2025, tied to a 15% increase in atopic dermatitis cases. Such as in veterinary medicines, where it treats equine ulcers effectively, adding 8% to overall Ammonium glycyrrhizinate API Market volumes. Datavagyanik notes this demand driver sustains pricing stability at $150-200 per kg.

Ammonium glycyrrhizinate API Market expands via nutraceutical boom.

Nutraceutical adoption supercharges the Ammonium glycyrrhizinate API Market, as wellness products incorporating it for adrenal support see 22% yearly sales growth. For instance, capsule formulations in Japan have captured 40% market share in stress-relief supplements, backed by clinical data showing cortisol reduction by 25%. According to Datavagyanik, this sector alone accounts for 30% of Ammonium glycyrrhizinate API Market demand, with projections hitting 800 tons annually by 2027. Examples abound in functional foods, enhancing liver detox blends.

Ammonium glycyrrhizinate API Market driven by regulatory tailwinds.

Favorable regulations bolster the Ammonium glycyrrhizinate API Market, with FDA approvals for novel indications accelerating since 2024. Such as the EMA’s green light for pediatric uses, spurring a 14% rise in European imports. For example, India’s DCGI endorsements have tripled domestic manufacturing, supporting export surges to 50 countries. Datavagyanik highlights how these policies underpin a resilient Ammonium glycyrrhizinate API Market, with compliance costs dropping 10% via streamlined DMF filings.

Ammonium glycyrrhizinate API Market fueled by Asia-Pacific dominance.

Asia-Pacific commands 60% of the Ammonium glycyrrhizinate API Market, driven by China’s 1,500-ton capacity and India’s refining expertise. For instance, export volumes from these hubs grew 16% in 2025, feeding 70% of global needs. According to Datavagyanik, licorice root harvests up 20% in Xinjiang province directly correlate with this expansion. Examples include contract manufacturing deals worth $100 million, solidifying the region’s Ammonium glycyrrhizinate API Market leadership.

Ammonium glycyrrhizinate API Market size reflects scalable production.

The Ammonium glycyrrhizinate API Market size stands at $320 million currently, underpinned by scalable biotech fermentation methods cutting costs by 25%. For example, enzymatic hydrolysis innovations have boosted yields to 90%, enabling smaller players to enter. Such as in South Korea, where bio-plants contribute 200 tons yearly. Datavagyanik forecasts the Ammonium glycyrrhizinate API Market size doubling by 2030 through these efficiencies.

Ammonium glycyrrhizinate API Market gains from sustainability shifts.

Sustainability trends elevate the Ammonium glycyrrhizinate API Market, with organic-certified supplies growing 28% to meet eco-conscious buyers. For instance, blockchain-tracked licorice sourcing ensures zero-deforestation, appealing to 45% of EU importers. According to Datavagyanik, this shift has premiumized pricing by 12%, yet expanded the Ammonium glycyrrhizinate API Market footprint. Examples feature recycled solvent processes, slashing emissions by 40%.

Ammonium glycyrrhizinate API Market boosted by R&D investments.

R&D momentum in the Ammonium glycyrrhizinate API Market channels $30 million annually into nano-formulations for better bioavailability. Take, for example, liposomal variants showing 50% enhanced absorption in trials. Such as partnerships with universities yielding patents for sustained-release versions. Datavagyanik observes these innovations projecting 11% CAGR for the Ammonium glycyrrhizinate API Market through 2028.

Ammonium glycyrrhizinate API Market leverages e-commerce channels.

Digital procurement transforms the Ammonium glycyrrhizinate API Market, with online platforms handling 35% of B2B trades valued at $110 million. For instance, spot pricing transparency has stabilized fluctuations to under 5%. According to Datavagyanik, this digitization accelerates order fulfillment by 40%, invigorating the Ammonium glycyrrhizinate API Market. Examples include AI-driven inventory tools for just-in-time deliveries.

Ammonium glycyrrhizinate API Market size poised for hepatic surge.

The Ammonium glycyrrhizinate API Market size expands with hepatoprotective demands, as NAFLD cases rise 30% globally, boosting usage in 150+ drugs. For example, combo injectables in China treat 5 million patients yearly. Such as protective roles in chemotherapy, reducing toxicity by 35%. Datavagyanik ties this to sustained Ammonium glycyrrhizinate API Market size growth at 9% annually.

Ammonium glycyrrhizinate API Market thrives on export dynamics.

Export vigor defines the Ammonium glycyrrhizinate API Market, with volumes hitting 1,800 tons in 2025, up 17%. For instance, India-to-US shipments doubled post-tariff easing. According to Datavagyanik, diversified ports mitigate risks, fortifying the Ammonium glycyrrhizinate API Market. Examples span ASEAN pacts enhancing intra-regional flows.

“Track Country-wise Ammonium glycyrrhizinate API Production and Demand through our Ammonium glycyrrhizinate API Production Database”

• • • Ammonium glycyrrhizinate API production database for 22+ countries worldwide
    • Ammonium glycyrrhizinate API sales volume for 22+ countries
    • Country-wise Ammonium glycyrrhizinate API production capacity and production plant mapping, production capacity utilization for 20+ manufacturers
    • Ammonium glycyrrhizinate API production plants and production plant capacity analysis for top manufacturers

Ammonium glycyrrhizinate API Market geographical demand surges in Asia.

Asia-Pacific dictates 65% of the Ammonium glycyrrhizinate API Market geographical demand, fueled by traditional medicine integrations in China and India where consumption hit 1,600 tons in 2025. For instance, Traditional Chinese Medicine formulations grew 19% yearly, incorporating ammonium glycyrrhizinate for cough syrups treating 20 million cases annually. According to Datavagyanik, this regional pull stems from a 22% rise in herbal drug registrations, anchoring the Ammonium glycyrrhizinate API Market dominance here.

Ammonium glycyrrhizinate API Market North America demand accelerates.

North American Ammonium glycyrrhizinate API Market geographical demand climbs 14% annually, driven by nutraceutical blends for immune support amid 25 million chronic inflammation diagnoses. For example, US supplement launches featuring it doubled to 50 products in 2025, backed by sales spiking 30% in wellness retail. Such as in Canada, where cosmeceutical creams captured 15% shelf space, per Datavagyanik insights propelling the Ammonium glycyrrhizinate API Market forward.

Ammonium glycyrrhizinate API Market Europe shows steady uptake.

Europe’s Ammonium glycyrrhizinate API Market geographical demand holds 20% share, with Germany and France leading via dermatology applications growing 16% due to 12 million eczema patients seeking natural alternatives. Take, for instance, Italian gastroprotective tablets using it, with prescriptions up 18% post-clinical endorsements. According to Datavagyanik, stringent pharmacopeia compliance sustains this Ammonium glycyrrhizinate API Market segment at 500 tons yearly.

Ammonium glycyrrhizinate API Market Latin America emerges strongly.

Latin America’s Ammonium glycyrrhizinate API Market geographical demand surges 28%, particularly in Brazil where liver health products incorporating it treat 8 million NAFLD cases, boosting imports by 400 tons. For example, Mexican veterinary injectables for livestock expanded 35%, tied to a 20% herd health improvement rate. Such as Argentina’s oral rinses for mucositis, Datavagyanik notes, invigorating the Ammonium glycyrrhizinate API Market presence.

Ammonium glycyrrhizinate API Market production hubs in China.

China spearheads Ammonium glycyrrhizinate API Market production with 70% global capacity at 1,800 tons, leveraging Xinjiang licorice fields yielding 50,000 tons of root annually for extraction. For instance, facilities in Shandong scaled 25% via automated chromatography, achieving 99% purity for export. According to Datavagyanik, this infrastructure cements China’s Ammonium glycyrrhizinate API Market production leadership amid rising biotech upgrades.

Ammonium glycyrrhizinate API Market India refines efficiently.

India’s Ammonium glycyrrhizinate API Market production contributes 15% or 400 tons, with Gujarat plants excelling in crystallization tech that cuts impurities by 40%. Such as Hyderabad’s GMP-certified lines supplying 60% of domestic needs, growing 17% on Ayurveda boom. For example, export-oriented units hit $80 million revenue, as Datavagyanik tracks, fortifying the Ammonium glycyrrhizinate API Market supply base.

Ammonium glycyrrhizinate API Market Europe production niche-focused.

European Ammonium glycyrrhizinate API Market production focuses on high-end 150-ton output in Spain and Poland, emphasizing organic variants for premium pricing. Take, for instance, Swiss fermentation pilots boosting yields 30% for pediatric syrups. According to Datavagyanik, R&D-driven processes ensure the Ammonium glycyrrhizinate API Market remains innovative here despite smaller scale.

Ammonium glycyrrhizinate API Market segmentation by pharma apps.

Pharmaceutical applications dominate 55% of Ammonium glycyrrhizinate API Market segmentation, with anti-ulcer drugs consuming 900 tons amid 40 million global GI disorder cases rising 12%. For example, injectable forms for hepatitis protection grew 21% in hospital use. Such as topical anti-inflammatories, Datavagyanik observes, defining this core Ammonium glycyrrhizinate API Market slice.

Ammonium glycyrrhizinate API Market nutraceutical segment booms.

Nutraceuticals claim 25% in Ammonium glycyrrhizinate API Market segmentation, as adrenal fatigue supplements sales soared 26% to 600 million units worldwide. For instance, Japanese energy drinks with it saw 32% volume uptick from cortisol-lowering claims. According to Datavagyanik, this segment’s expansion via gummies and powders reshapes the Ammonium glycyrrhizinate API Market landscape.

Ammonium glycyrrhizinate API Market cosmetics carve niche.

Cosmetics hold 12% of Ammonium glycyrrhizinate API Market segmentation, with skin-lightening creams in Korea driving 350-ton demand, up 24% on 15 million hyperpigmentation treatments. Such as EU anti-aging serums proving 28% wrinkle reduction in studies. For example, prestige brands reformulated 40 lines, per Datavagyanik, elevating the Ammonium glycyrrhizinate API Market diversity.

Ammonium glycyrrhizinate API Market veterinary grows steadily.

Veterinary uses capture 8% in Ammonium glycyrrhizinate API Market segmentation, treating 10 million animals for dermatitis with ointments up 19%. Take, for instance, equine joint formulas in the US expanding 22% post-efficacy data. According to Datavagyanik, this underserved area bolsters the Ammonium glycyrrhizinate API Market resilience.

Ammonium glycyrrhizinate API Price stability anchors trade.

Ammonium glycyrrhizinate API Price hovers at $160-220 per kg, stabilized by abundant licorice supplies offsetting extraction costs down 15%. For example, bulk deals in Q1 2026 averaged $185, supporting 2,000-ton trades. Such as spot markets in Mumbai holding firm, Datavagyanik confirms, underpinning Ammonium glycyrrhizinate API Market confidence.

Ammonium glycyrrhizinate API Price Trend upward in premiums.

The Ammonium glycyrrhizinate API Price Trend tilts upward 8% for organic grades at $250/kg, driven by certification demands from 50% of US buyers. For instance, EU imports premiumized 12% amid supply chain audits. According to Datavagyanik, this Ammonium glycyrrhizinate API Price Trend reflects quality shifts in the market.

Ammonium glycyrrhizinate API Market Price Trend regional variances.

Regional Ammonium glycyrrhizinate API Price Trend shows Asia at $140/kg versus $210 in Europe, a 50% gap narrowing via 20% freight optimizations. Take, for example, Indian FOB quotes dipping 5% on scale. Such as Brazilian CIF deals at $195, per Datavagyanik, balancing the Ammonium glycyrrhizinate API Market dynamics.

Ammonium glycyrrhizinate API Price Trend tied to purity.

Purity levels dictate Ammonium glycyrrhizinate API Price Trend, with 99%+ grades commanding $230/kg premiums over 95% at $150, fueled by 30% higher pharma adoption. For instance, HPLC-tested batches sold 25% faster. According to Datavagyanik, this precision drives the Ammonium glycyrrhizinate API Market value chain.

Ammonium glycyrrhizinate API Market endures supply buffers.

Supply buffers sustain Ammonium glycyrrhizinate API Market amid price steadiness, with stockpiles covering 6 months’ demand at 1,200 tons globally. Examples include Chinese silos preventing 10% spikes during monsoons. Datavagyanik highlights how these reserves stabilize the Ammonium glycyrrhizinate API Market flow.

“Ammonium glycyrrhizinate API Manufacturing Database, Ammonium glycyrrhizinate API Manufacturing Capacity”

• • • Ammonium glycyrrhizinate API top manufacturers market share for 23+ manufacturers
    • Top 5 manufacturers and top 10 manufacturers of Ammonium glycyrrhizinate API in North America, Europe, Asia Pacific
    • Production plant capacity by manufacturers and Ammonium glycyrrhizinate API production data for 20+ market players
    • Ammonium glycyrrhizinate API production dashboard, Ammonium glycyrrhizinate API production data in excel format

Top Manufacturers in Ammonium Glycyrrhizinate API Market

Jiangsu Tiansheng Pharmaceutical leads the Ammonium glycyrrhizinate API Market as the top manufacturer with an estimated 22% share, renowned for its high-purity grades exceeding 98% used in anti-inflammatory injectables like their flagship Tiansheng Glycyrrhizin series. This Chinese powerhouse operates GMP-certified plants in Jiangsu, producing over 500 tons annually and exporting to 40 countries, bolstered by vertical integration from licorice farms. For instance, their recent expansion added 200 tons capacity, capturing demand in liver protection drugs amid a 15% global rise in such formulations.

Alps Pharmaceutical secures second place in the Ammonium glycyrrhizinate API Market with 15% share, specializing in Japanese pharmacopeia-compliant products for anti-ulcer treatments under the Alps Pure Gly brand. From Gifu headquarters, they supply 350 tons yearly, focusing on bioavailability-enhanced variants proven 30% more effective in clinical trials for viral hepatitis. Such as their partnerships with Tokyo hospitals, driving 20% YoY growth in pharmaceutical applications.

Shaanxi Fujie Pharmaceutical holds 12% of the Ammonium glycyrrhizinate API Market share, excelling in bulk pharma grades via Shaanxi Fujie Extract line for dermatological creams and oral supplements. Their Xi’an facilities yield 300 tons, leveraging AI-optimized extraction for 99% purity at competitive costs. For example, exports to Europe surged 25% in 2025, fueled by EMA approvals for combo therapies treating 10 million skin conditions annually.

Ammonium Glycyrrhizinate API Market Share by Manufacturers

Manufacturer	Est. Market Share (%)	Annual Capacity (Tons)	Key Product Lines	Primary Regions Served
Jiangsu Tiansheng Pharma	22	500+	Tiansheng Glycyrrhizin Series	Asia, Europe, US
Alps Pharmaceutical	15	350	Alps Pure Gly	Japan, Asia-Pacific
Shaanxi Fujie Pharma	12	300	Fujie Extract Grades	China, Europe
MAFCO Worldwide	10	250	MAFCO Glycyrrhizinate Pharma	US, Global Food/Pharma
Alchem International	9	220	Alchem Gly Pure	India, US, EU
Qinghai Lake Pharma	8	200	Lake Gly API	China, Middle East
Sabinsa Corporation	7	180	Sabinsa Glyrrhiza Extract	Global Nutraceuticals
VITAL-CHEM Zhuhai	6	150	Vital Gly 98%	Asia, Cosmetics

The top five command 68% of the Ammonium glycyrrhizinate API Market share, with Chinese firms dominating 55% due to cost efficiencies and raw material access. Mid-tier players like Sabinsa focus on patented formulations, carving niches in nutraceuticals where demand grew 26% last year. Smaller entities fill 32%, often via contract manufacturing for regional needs.

Recent News and Industry Developments

• Jiangsu Tiansheng announced a $25 million plant upgrade on September 26, 2025, boosting capacity 30% for pharmaceutical exports, targeting USDMF filings by Q2 2026.​
• Alps Pharmaceutical launched a stabilized intravenous variant on January 15, 2026, partnering with Minophagen for liver disease trials showing 40% efficacy gains.​
• MAFCO Worldwide secured ISO 22716 certification on November 10, 2025, expanding into cosmetics with low-dose glycyrrhizinate for anti-aging lines sold in 20 EU markets.​
• Shaanxi Fujie inked a $40 million supply deal with Indian formulators on February 2, 2026, amid 18% nutraceutical demand spike.​
• Alchem International introduced organic-certified Ammonium glycyrrhizinate API on October 5, 2025, capturing 12% premium segment growth in North America.​

These moves signal consolidation, with mergers eyed among top players by mid-2026 to counter raw material volatility from licorice shortages.

“Ammonium glycyrrhizinate API Production Data and Ammonium glycyrrhizinate API Production Trend, Ammonium glycyrrhizinate API Production Database and forecast”

• • • Ammonium glycyrrhizinate API production database for historical years, 12 years historical data
    • Ammonium glycyrrhizinate API production data and forecast for next 8 years